Authors: Morgen, K Jeffries, NO Stone, R Martin, R Richert, ND Frank, JA McFarland, HF

Citation: K. Morgen et al., Ring-enhancement in multiple sclerosis: marker of disease severity, MULT SCLER, 7(3), 2001, pp. 167-171

Authors: Richert, ND Ostuni, JL Bash, CN Leist, TP McFarland, HF Frank, JA

Citation: Nd. Richert et al., Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis, MULT SCLER, 7(1), 2001, pp. 49-58

Authors: Richert, ND Zierak, MC Bash, CN Lewis, BK McFarland, HF Frank, JA

Citation: Nd. Richert et al., MRI and clinical activity in MS patients after terminating treatment with interferon beta-1b, MULT SCLER, 6(2), 2000, pp. 86-90

Authors: Ostuni, JL Richert, ND Lewis, BK Frank, JA

Citation: Jl. Ostuni et al., Characterization of differences between multiple sclerosis and normal brain: A global magnetization transfer application, AM J NEUROR, 20(3), 1999, pp. 501-507

Authors: Gobbini, MI Smith, ME Richert, ND Frank, JA McFarland, HF

Citation: Mi. Gobbini et al., Effect of open label pulse cyclophosphamide therapy on MRI measures of disease activity in five patients with refractory relapsing-remitting multiplesclerosis, J NEUROIMM, 99(1), 1999, pp. 142-149

Authors: Richert, ND Frank, JA

Citation: Nd. Richert et Ja. Frank, Magnetization transfer imaging to monitor clinical trials in multiple sclerosis, NEUROLOGY, 53(5), 1999, pp. S29-S32